Home > Insider Trading > Filing (0001181431-13-034256)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1183765	Threshold Pharmaceuticals Inc	THLD	Pharmaceutical Preparations (2834)	943409596

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1190474	E Wilfred Jaeger	3200 Alpine Drive Portola Valley CA 94028		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-06-07	94,898	$5.47	2,035,771	No	4	S	Indirect	See footnote
Common Stock	Disposition	2013-06-10	50,865	$5.50	1,984,906	No	4	S	Indirect	See footnote
Common Stock	Disposition	2013-06-07	5,102	$5.47	109,441	No	4	S	Indirect	See footnote
Common Stock	Disposition	2013-06-10	2,735	$5.50	106,706	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Footnotes

These shares are owned directly by Three Arch Partners III, L.P. ("TAP III"). Three Arch Management III, L.L.C. ("TAM III"), the general partner of TAP III, and Mark A. Wan and Wilfred E. Jaeger, the managing members of TAM III, may be deemed to share voting and dispositive power over the shares held by TAP III. Such persons and entities disclaim beneficial ownership of shares held by TAP III except to the extent of any pecuniary interest therein.
These shares are owned directly by Three Arch Associates III, L.P. ("TAA III"). Three Arch Management III, L.L.C. ("TAM III"), the general partner of TAA III, and Mark A. Wan and Wilfred E. Jaeger, the managing members of TAM III, may be deemed to share voting and dispositive power over the shares held by TAA III. Such persons and entities disclain beneficial ownership of shares held by TAA III except to the extent of any pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.50 to $5.51, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.